Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableLooking for participantsNCT06593964
What this trial is testing

TACE With Thermosensitive Nanogel Versus Embosphere for HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 188
Large-scale testing (Phase 3)Looking for participantsNCT05476432
What this trial is testing

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Study completedNCT00142467
What this trial is testing

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT05103904
What this trial is testing

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8+5 more
Emory University 3
Testing effectiveness (Phase 2)Looking for participantsNCT06555133
What this trial is testing

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Who this might be right for
Colorectal Carcinoma Metastatic in the Liver
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT02072486
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Hepatocellular CarcinomaStage III Childhood Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 30
Not applicableNot Yet RecruitingNCT07337031
What this trial is testing

A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

Who this might be right for
Primary Hepatocellular CarcinomaUnresectable Liver Cancer
Eastern Hepatobiliary Surgery Hospital 193
Testing effectiveness (Phase 2)Study completedNCT01387295
What this trial is testing

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Who this might be right for
Metastatic Breast CancerLiver Metastases
Dorte Nielsen 38
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Early research (Phase 1)WithdrawnNCT02989870
What this trial is testing

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Who this might be right for
HepatoCellular CarcinomaUnresectable HepatoCellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT05497453
What this trial is testing

Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Who this might be right for
Hepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more
Omega Therapeutics 24
Large-scale testing (Phase 3)Looking for participantsNCT06555003
What this trial is testing

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

Who this might be right for
Liver NeoplasmColorectal Cancer Metastatic
Tehran University of Medical Sciences 116
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Not applicableEnded earlyNCT01817205
What this trial is testing

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 8
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Not applicableLooking for participantsNCT07717437
What this trial is testing

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Who this might be right for
Liver CancerLiver Metastases
Maastricht University Medical Center 350
Next Page